A STING-activating nanovaccine for cancer immunotherapy.
Luo M, Wang H, Wang Z, Cai H, Lu Z, Li Y, Du M, Huang G, Wang C, Chen X, Porembka MR, Lea J, Frankel AE, Fu YX, Chen ZJ, Gao J.
Luo M, et al. Among authors: fu yx.
Nat Nanotechnol. 2017 Jul;12(7):648-654. doi: 10.1038/nnano.2017.52. Epub 2017 Apr 24.
Nat Nanotechnol. 2017.
PMID: 28436963
Free PMC article.